An Horizon Europe-funded project aiming to optimise Therapeutic Epigenetic Enhancement of the Innate Immunity to Effectively Combat Antimicrobial Resistance

EUROPE
Joined May 2023
🧪 IN-ARMOR reaches a new milestone in nanocarrier development! As part of WP3, led by @cinbio_uvigo , the project has successfully completed the optimisation and comprehensive characterisation of its mesoporous silica nanoparticle (MSNP)-based nanocarriers. #EUFunded #HaDEA #AMR
1
12
🚀 This achievement strengthens the integration of nanotechnology, drug development and biological validation within the IN-ARMOR pipeline, supporting the progression of selected candidates towards preclinical evaluation. #HostDirectedTherapy #Nanomedicine #DrugDelivery
1
3
Safety first in #INARMOR research! As part of WP4 (led by @Leitat ), our team completed the in vivo tolerability assessment and established Maximum Tolerated Dose (#MTD) profiles for our therapeutic candidates. Crucial groundwork before evaluating efficacy in disease models! 🧵👇
1
5
New milestone achieved! The consortium has completed the advanced characterisation of its selected lead compounds for host-directed therapies (HDTs) against antimicrobial resistance. 🔗 inarmor-project.eu/ #EUFunded #HaDEA #INARMOR #HorizonEurope #HostDirectedTherapy
1
6
🧪 Led by #LEITAT, with the key collaboration of #UniversityofIceland and WP2 partners, the team assessed key ADME-related properties, Caco-2 permeability and potential mechanisms of action. 🚀 Another step towards preclinical validation and innovative approaches to tackle #AMR.
2
Two days in Madrid, one shared roadmap for the final phase of #INARMOR! Our 4th Consortium Meeting brought together partners from across Europe to take stock of progress, discuss the path towards exploitation and impact, and align our priorities for the months ahead. #EUFunded
1
1
1
17
🏥 We also had the opportunity to connect our research with the clinical environment during a visit to the Microbiology Department at Hospital Universitario Ramón y Cajal, hosted by #SERMAS and @microRyC. 🚀 Next stop: the final phase of IN-ARMOR — and the IN-ARMOR Final Expo!
1
5
🧵 Day 1 of the 4th #INARMOR Consortium Meeting in Madrid is a wrap! Today, our 16 Horizon Europe partners came together to review key scientific and development milestones in the fight against antimicrobial resistance (#AMR). #EUFunded #HaDEA
1
1
3
41
🔬 Plenary session: Updates spanning molecule synthesis and innate immunity to nanomedicine and regulatory activities across WP1–WP5. 💡 Technical workshops: Focused discussions on the experimental strategy and the selection of lead compounds for further development.
1
15
🚨 IN-ARMOR partners meet in Madrid! 🇪🇺 On 16–17 September, we hold our 4th Consortium Meeting & 14th Management Board Meeting, hosted by @SaludMadrid. 🤝 2 days to review progress, strengthen collaboration and plan the next steps in the fight against #AMR. #EUFunded #HaDEA
1
1
1
22
✅ 2nd Periodic Review completed! Grateful to our Project Officer & external reviewers for their rigorous evaluation and guidance. Huge thanks to all partners for their dedication in advancing our fight against #AMR 🦠🧬 Let’s go for the final stage! 💪 #EUFunded #HaDEA
1
1
17
We’ve presented #INARMOR 's AI-driven approach to antimicrobial resistance to the #TUAI Spring School, a #MSCA doctoral training network focused on explainable, transparent, and trustworthy AI. That's how science moves forward. 🔗 inarmor-project.eu/ #EUFunded #HaDEA #AMR
1
20